A Phase 3, Pivotal, Open-Label, Multicenter Study to assess the efficacy and safety of BIVV009 in patients with Primary Cold Agglutinin Disease who have a recent history of blood transfusion

  • Chunilal, Sanjeev (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date18/08/18 → 8/08/21